Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: A case report

Netherlands Journal of Medicine

Volumn 67, Issue 1, 2009, Pages 25-28

  de Mol, P ^a   Meis, J F G M ^a  

^a CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

Corticosteroids; Disseminated zygomycosis; Non neutropenic; Rhizopus microsporus var. microsporus

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; GLIMEPIRIDE; GLUCOSE; HEMOGLOBIN; ITRACONAZOLE; MOXIFLOXACIN; PREDNISOLONE; VORICONAZOLE;

ABDOMINAL PAIN; AGED; ARTICLE; BRONCHOSCOPY; CANDIDA ALBICANS; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REDUCTION; DYSPNEA; HEMATURIA; HUMAN; HYPERGLYCEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; KIDNEY INFARCTION; LUNG ASPERGILLOSIS; LUNG HEMORRHAGE; LUNG LAVAGE; MALE; MUCORMYCOSIS; RESPIRATORY FAILURE; RHIZOPUS; RHIZOPUS MICROSPORUS; THORAX RADIOGRAPHY;

ADRENAL CORTEX HORMONES; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; ANTIFUNGAL AGENTS; CIPROFLOXACIN; FATAL OUTCOME; HUMANS; ITRACONAZOLE; MALE; MUCORMYCOSIS; PREDNISOLONE; PYRIMIDINES; RHIZOPUS; TRIAZOLES;

EID: 58849157356     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kerr PG, Turner H, Davidson A, Bennett C, Maslan M. Zygomycosis requiring amputation of the hand: an isolated case in a patient receiving haemodialysis. Med J Aust. 1988;148:258-9.
2. Kwon-Chung KJ, Bennett JE. Mucormycosis. In: Medical mycology. Philadelphia: Lea & Febiger, 1992. p. 524-59.
3. West BC, Oberle AD, Kwon-Chung KJ. Mucormycosis caused by Rhizopus microsporus var. microsporus: cellulitis in the leg of a diabetic patient cured by amputation. J Clin Microbiol. 1995;33:3341-4.
4. Kobayashi M, Hiruma M, Matsushita A, Kawai M, Ogawa H, Udagawa S. Cutaneous zygomycosis: a case report and review of Japanese reports. Mycoses. 2001;44:311-5.
5. Verweij PE, van der Velden WJFM, Donnelly JP, Blijlevens NMA, Warris A. Invasive zygomycosis in patients treated for haematological malignancies. Ned Tijdschr Geneeskd. 2007;151:597-602.
6. Peel T, Daffy J, Thursky K, Stanley P, Buising K. Posaconazole as first line treatment for disseminated zygomycosis. Mycoses 2008; doi:10.1111/ j.1439-0507.2008.01499.x (online article).
7. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000;13:236-301.
8. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect. 2004;10(suppl 1):31-47.
9. Eucker J, Sezer O, Graf B, Possinger K. Mucormycoses. Mycoses. 2001;44:253-60.
10. Chayakulkeeree M, Ghannoum MA, Perfect JR. Zygomycosis: the re-emerging fungal infection. Eur J Clin Microbiol Infect Dis. 2006;25:215-29.
11. Nosari A, Oreste P, Montillo M, et al. Mucormycosis in haematological malignancies: an emerging fungal infection. Haematologica. 2000;85:1068-71.
12. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005;41:634-53.
13. Glazer M, Nusair, Breuer R, Lafair J, Sherman J, Berkman N. The role of BAL in the diagnosis of pulmonary mucormycosis. Chest. 2000;117:279-82.
14. McAdams HP, Rosado de Christenson M, Strollo DC, Patz EF. Pulmonary mucormycosis: Radiologic findings in 32 cases. Am J Roentgenol. 1997;168:1541-8.
15. Greenberg RN, Scott LJ, Vaughn HH, Ribes JA. Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis. 2004;17:517-25.
16. Tarrand JJ, Lichterfeld M, Warraich I, et al. Diagnosis of invasive septate mold infections. A correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol. 2003;119:854-8.
17. Greenberg RN, Mullane K, van Burik AH, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50(1):126-33.
18. Dannaoui E, Meletiadis J, Mouton J, Meis JFGM, Verweij PE. In vitro susceptibilities of Zygomycetes to conventional and new antifungals. J Antimicrob Chem. 2003;51:45-52.
19. Dannaoui E, Meis JFGM, Loebenberg D, Verweij PE. Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chem. 2003;47:3647-50.
20. Kontoyiannis DP, Lionakis MS, Lewis RE, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis. 2005;191:1350-9.